Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Archives of Internal Medicine

• Publication date

  2003-07-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.163.13.1580PMID 12860581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation.

  2002cited by this paper
• Use of Aspirin, Epistaxis, and Untreated Hypertension as Risk Factors for Primary Intracerebral Hemorrhage in Middle-Aged and Elderly People

  2001cited by this paper
• Use of Aspirin, Epistaxis, and Untreated Hypertension as Risk Factors for Primary Intracerebral Hemorrhage in Middle-Aged and Elderly People

  2001cited by this paper
• Hemorrhagic complications of anticoagulant treatment.

  2001cited by this paper
• Spontaneous intracerebral hemorrhage.

  2001cited by this paper
• Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation

  2001cited by this paper
• Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

  2001cited by this paper
• Oral anticoagulants: Pharmacologic issues for use in the elderly

  2001cited by this paper
• Antithrombotic therapy in atrial fibrillation.

  2001cited by this paper
• The Sharer

  2000cited by this paper
• Anticoagulation therapy for patients with atrial fibrillation.

  2000cited by this paper
• Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.

  2000cited by this paper
• Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation.

  2000cited by this paper
• Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy.

  2000cited by this paper
• Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

  1999cited by this paper
• Major bleeding after hospitalization for deep-venous thrombosis.

  1999cited by this paper
• Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.

  1999influential reference
• Bleeding peptic ulcers: audit of eradication treatment for H pylori.

  1999cited by this paper
• Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.

  1999cited by this paper
• Audit of the frequency and clinical response to excessive oral anticoagulation in an out‐patient population

  1998cited by this paper
• Risk of major hemorrhage for outpatients treated with warfarin

  1998cited by this paper
• The effect of age and quality of life on doctors' decisions to anticoagulate patients with atrial fibrillation

  1998cited by this paper
• Acetaminophen and other risk factors for excessive warfarin anticoagulation.

  1998cited by this paper
• Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

  1998cited by this paper
• Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation.

  1998cited by this paper
• Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke.

  1998cited by this paper
• A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

  1998cited by this paper
• A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin

  1997cited by this paper
• The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.

  1997cited by this paper
• Determinants of compliance with anticoagulation: A case-control study.

  1997cited by this paper
• Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

  1996cited by this paper
• Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

  1996cited by this paper
• Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation

  1996cited by this paper
• Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

  1996cited by this paper
• Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics.

  1996cited by this paper
• National patterns of warfarin use in atrial fibrillation.

  1996cited by this paper
• Why isn’t warfarin prescribed to patients with nonrheumatic atrial fibrillation?

  1996cited by this paper
• The Utilization of Antithrombotic Prophylaxis for Atrial Fibrillation in a Geriatric Rehabilitation Hospital

  1996cited by this paper
• Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

  1996cited by this paper
• The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin

  1996cited by this paper
• Warfarin for atrial fibrillation. The patient's perspective.

  1996cited by this paper
• Should we just let the anticoagulation service do it?

  1996cited by this paper
• Management and Prognosis of Life-threatening Bleeding During Warfarin Therapy

  1996cited by this paper
• Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.

  1995cited by this paper
• Age-associated risks of prophylactic anticoagulation in the setting of hip fracture.

  1995cited by this paper
• Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.

  1995cited by this paper
• Long‐term anticoagulant therapy in cerebrovascular disease: does bleeding outweigh the benefit?

  1995cited by this paper
• Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

  1995cited by this paper
• Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs

  1995cited by this paper
• Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.

  1995cited by this paper
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.

  1994cited by this paper
• Omission Bias and Pertussis Vaccination

  1994cited by this paper
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

  1994cited by this paper
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation : stroke prevention in atrial fibrillation II study. Commentary

  1994cited by this paper
• Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.

  1994cited by this paper
• Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin

  1994cited by this paper
• Therapeutic support of the patient with thrombocytopenia.

  1994cited by this paper
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study

  1994cited by this paper
• Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study

  1993cited by this paper
• Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

  1993cited by this paper
• Bleeding complications in oral anticoagulant therapy : an analysis of risk factors

  1993cited by this paper
• Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease.

  1993cited by this paper
• Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke

  1993cited by this paper
• Ischemic and Hemorrhagic Stroke in Patients on Oral Anticoagulants After Reconstruction for Chronic Lower Limb Ischemia

  1993cited by this paper
• Bleeding Complications in Oral Anticoagulant Therapy

  1993cited by this paper
• Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.

  1992cited by this paper
• Hemorrhagic complications of anticoagulant treatment.

  1992cited by this paper
• Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients

  1991cited by this paper
• Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities

  1991cited by this paper
• Trial of different intensities of anticoagulation in patients with prosthetic heart valves.

  1990cited by this paper
• Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities.

  1990cited by this paper
• Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin.

  1989cited by this paper
• Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis

  1989cited by this paper
• Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy.

  1989cited by this paper
• Anticoagulation-related intracranial extracerebral haemorrhage.

  1989cited by this paper
• Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement.

  1988cited by this paper
• Age-related risks of long-term oral anticoagulant therapy.

  1988cited by this paper
• Complications of long‐term anticoagulation

  1988cited by this paper
• Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage.

  1986cited by this paper
• Hemorrhagic complications of long-term anticoagulant therapy.

  1986cited by this paper
• Acute subdural haematomas: aetiology, pathology and outcome.

  1986cited by this paper
• Hypertension as a risk factor for spontaneous intracerebral hemorrhage.

  1986cited by this paper
• The 'chagrin factor' and qualitative decision analysis.

  1985cited by this paper
• Subdural hematoma. A retrospective study of the 'great neurologic imitator'.

  1985cited by this paper
• Anticoagulant‐related intracerebral hemorrhage

  1985cited by this paper
• The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study

  1984cited by this paper
• Judgement under Uncertainty: Heuristics and Biasses

  1983cited by this paper
• History and methods

  1983cited by this paper
• Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

  1982cited by this paper
• Subdural hematoma and oral anticoagulant therapy.

  1982cited by this paper
• How decisions are reached: physician and patient.

  1982cited by this paper
• Hémorragies intra-crâniennes et intra-rachidiennes chez des malades sous traitement anticoagulant. A propos de 33 cas.

  1980cited by this paper
• [Intracranial and intraspinal hemorrhage in patients on anticoagulant treatment. Apropos of 33 cases].

  1980cited by this paper
• The cause of bleeding during anticoagulant treatment.

  1965cited by this paper

• An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire

  2023cites this paper
• BARRIERS TO GUIDELINE-DIRECTED ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION NEW APPROACHES TO AN OLD PROBLEM.

  2023cites this paper
• Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation

  2022cites this paper
• Combater o Sangramento – Um Apêndice de Cada Vez

  2022cites this paper
• Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new‐onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study

  2021cites this paper
• Circulation: Cardiovascular Quality and Outcomes

  2021cites this paper
• The Introduction of Direct Oral Anticoagulants Has Not Resolved Treatment Gaps for Frail Patients With Nonvalvular Atrial Fibrillation.

  2021cites this paper
• Integrated Care in Atrial Fibrillation

  2021cites this paper
• Epidemiology and Primary Prevention of Stroke.

  2020cites this paper
• Minor bleeding affects the level of knowledge in patients with atrial fibrillation on oral anticoagulant therapy

  2020influential citation
• Use of Anticoagulants in Patients With Non-Valvular Atrial Fibrillation Who Are at Risk of Falls

  2020cites this paper
• Zerebrale Mikroangiopathie

  2020cites this paper
• Atrial fibrillation in elderly patients with implantable loop recorders for unexplained syncope

  2019cites this paper
• Stroke in the elderly.

  2019cites this paper
• Primärprävention und Sekundärprävention des Hirninfarkts

  2019cites this paper
• Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study

  2019cites this paper
• Rivaroxaban administration after acute ischemic stroke: The RELAXED study

  2019cites this paper
• Anticoagulation Patterns in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention in an Academic Center

  2019cites this paper
• Real-life Performance of Edoxaban in Elderly Patients With Atrial Fibrillation: a Multicenter Propensity Score-Matched Cohort Study.

  2019cites this paper
• Barriers to a software reminder system for risk assessment of stroke in atrial fibrillation: a process evaluation of a cluster randomised trial in general practice.

  2018cites this paper
• Factors associated with discontinuing or not starting oral anticoagulant therapy in older hospitalized patients with non‐valvular atrial fibrillation

  2018cites this paper
• Contemporary approach to stroke prevention in atrial fibrillation: Risks, benefits, and new options.

  2018cites this paper
• Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case‐control study

  2018cites this paper
• Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS2 Score ≥ 2: Are We Doing Better Since the Marketing of Direct Oral Anticoagulants?

  2017cites this paper
• Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF.

  2017cites this paper
• Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: Has Prescribing Improved?

  2017cites this paper
• Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation.

  2017cites this paper
• Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients

  2017cites this paper
• Oral anticoagulation in patients with atrial fibrillation and medical non-neoplastic disease in a terminal stage

  2017cites this paper
• Patient Characteristics and Antithrombotic Prescribing Patterns in Patients With Atrial Fibrillation in Tasmania

  2017cites this paper
• Antithrombotic therapy in patients with atrial fibrillation : the Tasmanian experience

  2016influential citation
• Combination of Oral Anticoagulant with Antiplatelet and All-cause Mortality in Elderly Patients with Atrial Fibrillation and Ischemic Heart Disease

  2016cites this paper
• The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients.

  2016cites this paper
• Warfarin Treatment and All‐Cause Mortality in Community‐Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study

  2016cites this paper
• How can I predict bleeding in my elderly patient taking anticoagulants?

  2016cites this paper
• Characteristics of falls producing hip fracture in patients on oral anticoagulants

  2016cites this paper
• Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross‐sectional baseline analysis in general practice

  2016cites this paper
• Clinical Research The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients

  2016cites this paper
• Addressing Disparities in Stroke Prevention for Atrial Fibrillation

  2016cites this paper
• Oral Anticoagulation in the Elderly: New Oral Anticoagulants–Innovative Solution for an Old Problem?

  2016cites this paper
• Prior bleeding, future bleeding and stroke risk with oral anticoagulation in atrial fibrillation: What new lessons can ARISTOTLE teach us?

  2016cites this paper
• Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants

  2015cites this paper
• Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry

  2015cites this paper
• [Anticoagulation in the aged patient with atrial fibrillation: What are prescribing cardiologists, geriatricians and general practitioners?].

  2015cites this paper
• L’anticoagulation du patient âgé en fibrillation atriale : que prescrivent les cardiologues, les gériatres et les médecins généralistes ?

  2015cites this paper
• Hospitalisierte geriatrische Patienten mit Vorhofflimmern sind nicht ausreichend mit Antikoagulanzien behandelt

  2015cites this paper
• Unterversorgung von Vorhofflimmer-Patienten mit oralen Antikoagulanzien in Deutschland

  2015cites this paper
• Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation

  2015cites this paper
• [Insufficient use of anticoagulants in geriatric in-patients with atrial fibrillation and flutter (corrected)].

  2015cites this paper
• Stroke prophylaxis in atrial fibrillation: searching for management improvement opportunities in the emergency department: the HERMES-AF study.

  2015cites this paper
• Optimal Stroke Prevention in the Geriatric Patient with Atrial Fibrillation: Position Paper of an Interdisciplinary Expert Panel.

  2015cites this paper
• Conundrums for Atrial Fibrillation Management in Older Adults

  2015cites this paper
• Race/Ethnicity in Atrial Fibrillation Stroke: Epidemiology and Pharmacotherapy.

  2015cites this paper
• Novel Oral Anticoagulants for Stroke Prevention in the Geriatric Population

  2014cites this paper
• Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age.

  2014cites this paper
• Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.

  2014cites this paper
• Attitudes and Preferences of the Use of Mobile Health Technology and Health Games for Self-Management in Older Adults on Anticoagulation Therapy

  2014cites this paper
• Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?

  2014cites this paper
• Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation

  2014influential citation
• Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians

  2014influential citation
• [The use of dabigatran for prevention of ischemic stroke in patiets with atrial fibrillation: special features of treatment in different clinical situations].

  2014cites this paper
• Oral Anticoagulation Therapy for Elderly Patients With Atrial Fibrillation

  2014cites this paper
• Attitudes and Preferences on the Use of Mobile Health Technology and Health Games for Self-Management: Interviews With Older Adults on Anticoagulation Therapy

  2014cites this paper
• Optimal Stroke Prevention in the Geriatric Patient with Atrial Fibrillation: Position Paper of an Interdisciplinary Expert Panel

  2014cites this paper
• Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.

  2014cites this paper
• Gastrointestinal comorbidities associated with atrial fibrillation

  2014cites this paper
• THE EFFICACY AND SAFETY OF THE NOVEL ANTICOAGULANTS IN ELDERLY ADULTS

  2014cites this paper
• Adherence to guidelines and mortality in atrial fibrillation.

  2014cites this paper
• Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.

  2014cites this paper
• The Pharmacology and Therapeutic Use of Dabigatran Etexilate

  2013cites this paper
• Venous thromboembolism prophylaxis in the nursing home: to do or not to do?

  2013cites this paper
• Target specific oral anticoagulants in the management of thromboembolic disease in the elderly

  2013cites this paper
• Recent Advances in Antithrombotic Therapy for Stroke Prevention in Patients With Atrial Fibrillation

  2013cites this paper
• Bleeding Risk Prediction Models in Atrial Fibrillation

  2013cites this paper
• New thrombin and factor Xa inhibitors for primary and secondary prevention of ischaemic stroke.

  2013cites this paper
• The evolving role of stroke prediction schemes for patients with atrial fibrillation.

  2013cites this paper
• New oral anticoagulants in elderly patients with atrial fibrillation.

  2013cites this paper
• Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation

  2013cites this paper
• Oral Anticoagulation in Elderly Adults with Atrial Fibrillation: Integrating New Options with Old Concepts

  2013cites this paper
• Atrial fibrillation in heart failure in the older population.

  2013cites this paper
• Covariates to Better Understand and Moderate Risks Oral Anticoagulation Therapy for Elderly Patients With Atrial Fibrillation : Utility of Bleeding Risk

  2013cites this paper
• Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient

  2013cites this paper
• New atrial fibrillation guidelines: implementation in the clinic

  2013cites this paper
• A GREAT LEAP FORWARD IN THE MANAGEMENT OF ATRIAL FIBRILLATION

  2013cites this paper
• Risk of falls and major bleeds in patients on oral anticoagulation therapy.

  2012cites this paper
• How Can We Avoid a Stroke Crisis in Europe

  2012cites this paper
• Advances in the management of atrial fibrillation.

  2012cites this paper
• Effects of computer-assisted oral anticoagulant therapy

  2012cites this paper
• The antithrombotic management of atrial fibrillation

  2012cites this paper
• Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients.

  2012cites this paper
• Atrial fibrillation and atrial flutter: nonpharmacologic therapy.

  2012cites this paper
• Gastrointestinal hemorrhage and antithrombotic drug use in geriatric patients

  2012cites this paper
• Clinical barriers to the use of recommended stroke prevention therapy

  2012cites this paper
• Atrial Fibrillation-Related Stroke across the Asia-Pacific Region: A Preventable Problem

  2012cites this paper
• Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"?

  2012cites this paper
• Neue Antikoagulanzien zur Schlaganfallprävention bei Vorhofflimmern

  2012cites this paper
• Atrial fibrillation: stroke prevention in older adults.

  2012cites this paper
• Analyse qualitative de la prescription des anticoagulants dans la fibrillation atriale des sujets âgés en EHPAD

  2012cites this paper
• Stroke prevention in atrial fibrillation: do we still need warfarin?

  2012cites this paper
• Polypharmacy: what clinicians need to know while caring for an elder.

  2012cites this paper